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Mode of actionViral infections remain amajor threat to humans and animals and there is a crucial need for new antiviral agents
especially with the development of resistant viruses. Several Limonium genus members (Plumbaginacea) have
been widely used in traditional medicine for the treatment of infections. In this study, we investigated the
antiviral activities of different fractions after successive extraction (hexane, dichloromethane, ethanol and
methanol) of the halophyte Limonium densiﬂorum against H1N1 inﬂuenza and HSV-1 herpes viruses. In addition,
TLC phytochemicals of the shoot extracts were analyzed. All extracts were tested for their cytotoxicity using a
ﬂuorometric resazurin assay. The antiviral activity of extracts was tested using four modes of action: virucidal
test, pretreatment of cells with samples before infection, attachment assay and plaque reduction test. A good an-
tiviral activity was found with ethanol and methanol extracts. They were most potent in HSV-1 inhibition than
H1N1 inﬂuenza virus. Themost potent inhibition was observed with ethanol extract, and it exhibited high levels
of virucidal activity against HSV-1 (IC50 = 6 μg/mL). It inhibits the replication of the virus by 75% when added
after penetration of the virus, and by 100% when added during the viral attachment. It protects MDCK cells
against inﬂuenza virus by abolishing virus to entry into the host cell (IC50 = 55 μg/mL). After attachment of
inﬂuenza virus, the ethanol extract displayed an appreciable inhibition of virus replication (IC50 = 193 μg/mL).
Methanol extract showed a moderate antiviral capacity against both viruses. While dichloromethane has
excellent antiherpes potential, results were inappropriate because it was toxic to Vero cells, hexane extract has
no effect. TLC analysis of these extracts showed that ﬂavonoids and saponins were the major classes of natural
products found in the shoot extracts that may be responsible for these antiviral activities.
© 2014 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
Frequent human infections of viral origin could be exempliﬁed as
commonHIV, AIDS, cold inﬂuenza, HSV etc. (Orhan et al., 2009). Herpes
simplex virus (HSV) causes a variety of diseases in humans, with differ-
ent degrees of severity, ranging frommild to severe, and in certain cases,
it may even lead to life-threatening conditions. Herpes simplex virus
infection is characterized by watery blisters on the skin or mucous
membranes of the mouth, lips or genitals. It stands out because of the
wide variety of clinical symptoms they provoke, including oral and gen-
ital vesicular lesions, eczema, encephalitis, pneumonia and hepatitis
(Alvareza et al., 2009). After the primary infection, HSV-1 trends to
persist in the neuron of the ganglia. Reactivation of latent HSV which
is very common during the deﬁciency of immunity causes recurrent
herpes infection (Loizzo et al., 2008). According to epidemiological
surveys, the HSV infection rate has continuously increased in most216 79 412 638.
hts reserved.countries (Chuanasa et al., 2008). Inﬂuenza is a serious global conta-
gious disease that leads to hundreds of thousands of deaths every year
(Zhao and Akber, 2012). There are currently three types of inﬂuenza
A, B and C based on the antigenic and genetic differences of the inner
proteins and genome structure. Inﬂuenza A is an important human
pathogen that has an impact on the global health. After the pandemic
period, the viruses still occur at high levels in winter as seasonal ﬂu
strains.
Viral vaccines and anti-viral drugs are the primarymeans for protec-
tion against and treatment of infections. For instance, nucleoside
analogs, acyclovir (ACV) and other nucleoside derivatives, valaciclovir,
and ganciclovir have been approved for treatment of HSV infections
worldwide (Leung and Sacks, 2000; Brady and Bernstein, 2004).
Oseltamivir phosphate, an orally administered drug, was used for the
prophylaxis and treatment of human inﬂuenza A and B and it is the
most promising drug for the treatment of inﬂuenza virus (Moscana,
2005). However, in the appearance of resistant viruses, virus is a current
problem. The failure of treatment of HSV-1 is also due to the recurrence
of latent viruses (Field and Biron, 1994). Besides, the highmutation rate
of inﬂuenza virus also limits the effect of inﬂuenza vaccine. The vaccine
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that the inﬂuenza virus has shown resistant to oseltamivir (Zhao and
Akber, 2012). For these reasons, there is still a need in the future to
search for new and more effective antiviral agents that can substitute
or complement currently used antiviral medicines.
Ethopharmacology provides scientists with an alternative approach
for the discovery of antiviral agents, namely the study of medicinal
plants with a history of traditional use as a potential source of
substances with signiﬁcant pharmacological and biological activities
(Cos et al., 2011). According to the literature, a great number of salt-
tolerant medicinal plants (halophytes) are used to treat various dis-
eases, viral infections and aging processes particularly in the rural
areas, where the traditional folk medicine remains a major source to
cure minor ailments (Ksouri et al., 2011). Halophyte plants are able to
withstand hard climatic conditions which generate oxidative stresses
by the production of antioxidant system. There are more than 2500
halophyte species knownworldwide to possess some salinity tolerance,
and among them, several could be suitable candidates to be used as cash
crops. For instance, Cakile maritima had diuretic, antiscorbutic, digestive
and purgative properties (Davy et al., 2006), Limonium spp. is known
also in a folk medicine. LimoniumMill is a genus of 180 species, widely
disturbed in different salt regions of the world for example, Limonium
brasiliense is known as cardioprotective for anti-bacterial and anti-
inﬂammatory properties (Murray et al., 2004) and Limonium wrightii
is used for the treatment of fever or arthritis (Aniya et al., 2002). In
addition, Limonium sinense and Limonium tetragonum show antiviral
activity (Yuh-Chi et al., 2002), whereas, Limoniumaxillare and Limonium
californicum show cytotoxic and antibacterial activities (Kandil et al.,
2000; Sakagami et al., 2001).
In previous work Limonium densiﬂorum exhibited a potent antioxi-
dant activity (Medini et al., 2011). Our research approach aimed to
discover novel plant derived natural products as new leads, which
could be developed for the treatment of viral infectious diseases.
L. densiﬂorum is a rosette plant from coastal regions and salt ﬂat. It can
tolerate a wide range of environmental conditions and resist to abiotic
stresses such as salt, high temperature, and water deﬁcit stress.
In the course, we examined the inhibitory effect of different fractions
of the halophyte L. densiﬂorum against herpes simplex type 1 (HSV-1)
and inﬂuenza A viruses, and have an idea about mode of action of
these extracts. Besides TLC phytochemicals was investigated.
2. Materials and methods
2.1. Cells for anti-herpes activity
The African Green Monkey Kidney cells (Vero cells ATCC: CCL81)
were grown in monolayer culture with M199 medium supplemented
with 10% fetal calf serum (Hyclone, Logan, USA), solution of vitamins
(1×), sodium pyruvate (1×), non-essential amino acids (1×), penicillin
(100 IU) and streptomycin (100 μg/mL). Themonolayerswere removed
from their plastic surfaces and serially passagedwhenever they became
conﬂuent.
2.2. Cells for anti-inﬂuenza activity
Madin-Darby Canine Kidney (MDCK cells: CCL34)were kept inmin-
imum essential medium (MEM) supplemented with 5 mL penicillin/
streptomycin, 10% BSA (1%), 0.025% trypsin solution and 0.025% glucose
solution.
2.3. Viruses
Herpes simplex virus type 1 (HSV-1; 15577 strain) and inﬂuenza A
viruses (H1N1 strain) were purchased from the American Type Culture
Collection (ATCC, Rockville, MD). They were kindly provided by Laval
University, Canada. All virus stocks were stored at−80 °C until use.2.4. Plant material and preparation of crude plant extract
L. densiﬂorum specimen was harvested from salt ﬂat (Sebkha) from
Kairouan city (semi arid climate). The harvested plants were identiﬁed
at the Biotechnology Center at the Technopark of Borj-Cedria, and a
voucher specimen (PLM30) was deposited at the herbarium of the
Laboratory of Extremophile Plants at the Biotechnology Center. Shoots
were rinsed with distilled water, left at room temperature for 7 days
in the dark, and then oven dried for 24 h at 50 °C. Extracts were obtain-
ed by successive extraction in Soxhlet using several solvents (hexane,
dichloromethane, methanol and ethanol). Afterwards, the extracts
were ﬁltered, and solvent was evaporated under reduced pressure
using rotary vacuum evaporator. At last, shoot extracts were stored
and the residue was reconstituted in dimethyl sulphoxide (DMSO) be-
fore testing.
2.5. Cytotoxicity assay
For cytotoxicity assay, cellswere seeded into 96-well plates at a den-
sity of 5 ∗ 103 cells perwell and incubated for 24 h at 37 °C. Themedium
was removed and fresh DMEM containing the appropriate concentra-
tion of the L. densiﬂorum extracts was added onto conﬂuent appropriate
cells. All extracts were dissolved in DMSO and added to themedium at a
ﬁnal concentration of 1% DMSO, well containing 1% DMSO but without
drug or extract was also included on each plate as control. After 4 days
of incubation, the cytotoxicity was assessed using the resazurin reduc-
tion test as described by O'Brien et al. (2000). Measurements of ﬂuores-
cence were carried out after 96 continuous hours of contact between
extracts and cells on an automated 96-well Fluoroskan Ascent Fl™
plate reader (Labsystems) using an excitation wavelength of 530 nm
and an emission wavelength of 590 nm. Results are expressed as the
concentration inhibiting 50% of the cell growth (IC50). The cell morphol-
ogy was observed under the microscope.
2.6. Antiherpes activity
Cells and viruses were incubated with acyclovir or extracts at differ-
ent stages during the viral infection cycle in order to determine the
mode of antiviral action. All extracts were dissolved in DMSO and
added to the medium at a ﬁnal concentration of 1% solvent; wells con-
taining 1% solvent but without drug were also included on each plate
as controls.
2.6.1. Direct virucidal effect of extracts on HSV-1
Viral suspension was incubated with different concentrations of
extracts at 37 °C for 1 h. (Camargo et al., 2008). The mixture was then
used to infect Vero cells for 1 h. After that, it was removed; wells were
washedwith PBS (pH 7.4) and incubatedwithmethylcellulose/medium
0.5% for 72 h. After 3 days, mediumwas aspirated and the infected cells
were ﬁxed with 10% formalin, stained with 1% crystal violet, and the
number of plaques was counted (Rechter et al., 2006). The wells over-
laid with medium without test sample were used as the controls. The
percentage of inhibition of plaque formation was calculated as follows:
[(mean number of plaques in control)− (mean number of plaques in
sample)] × 100/mean number of plaques in control. Results are
expressed as IC50 (μg/mL).
2.6.2. Effect of test samples before virus infection
Conﬂuent Vero cells in 24-well tissue culture plates were washed
with PBS. 100 μL of culture medium containing different concentrations
of test extractswere added to eachwell, and the cellswere incubated for
1 h at 37 °C and 5% CO2. After removal of the extract, the cells were
washed with PBS and then infected with 30 pcf/well of HSV-1. After 1
h incubation, the cells were washed with PBS twice to remove any
unabsorbed virus, and further incubated in medium containing 0.5%
methylcellulose for 72 h. Next, cells were ﬁxed with formaldehyde
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counted (Papazisis et al., 1997).2.6.3. Effect of test samples during the infection
The assay was performed as described above, with the exception
that the test extract was added togetherwith the virus. After 1 h incuba-
tion, the solution containing unabsorbed virus was removed, and the
cell monolayer was washed with PBS and further incubated in DMEM/
methylcellulose for 72 h. The virus-induced cellular lysis was expressed
as inhibition percent (%) (Camargo et al., 2008).2.6.4. Plaque reduction assay
Infection assayswere performedwithHSV-1 onVero cells in 24-well
plates. Following viruses were adsorbed at 37 °C for 60 min, inoculi
were removed and 0.5% methylcellulose overlays, optionally supple-
mentedwith drug or extracts, were added to thewells. After incubation
for 3 days at 37 °C, the infected cells were ﬁxed with 10% formalin,
stained with 1% crystal violet, and the number of plaques was counted
(Rechter et al., 2006). The wells overlaid with medium without test
sample were used as the control. The percentage of inhibition of plaque
formation was calculated as follows: [(mean number of plaques in
control)− (mean number of plaques in sample)] × 100/mean number
of plaques in control. Acyclovirwas used as a positive control drug in the
anti-HSV1 study.2.7. Anti-inﬂuenza activity
2.7.1. Virucidal effect
Inﬂuenza A viruses were incubated in medium containing the ex-
tract for 1 h at room temperature prior to infection of MDCK cells.
After 1 h of adsorption of themixture (virus-extract) at 37 °C, the inoc-
ulumwas removed and cells were overlaid with mediumMEM/BSA for
4 days. The anti-inﬂuenza virus capacity was assayed by quantifying of
theﬂuorescent production in response to the ‘chemical reduction’ of the
medium resulting from cell growth or by mitochondrial enzymes in
host cells (resazurin test). After 4 days, the ﬂuorescence of themedium
was recorded for the excitationwavelength530nmand emissionwave-
length 590 nm. The inhibition ratio was obtained using the equation:
Inhibition activity (%) = (Fextract − Fvirus) / (Fcontrol − Fvirus) ∗ 100
where FVirus is the ﬂuorescence of the inﬂuenza virus control
(virus, buffer and medium), Fcontrol is the ﬂuorescence of the drug
control (buffer and drug), and Fextract is the ﬂuorescence of the tested
samples (virus, sample solution, medium). Subsequently, the 50%
inhibitory concentration (IC50) was determined by extrapolation of
the results from various doses tested using a linear equation. At least
three independent measurements were collected to determine the
mean and SD values.2.7.2. Effect of test samples before virus infection
Cells monolayer was pretreated with the L. densiﬂorum extract or
oseltamivir, for 1 h at 37 °C. The extract was aspirated and cells were
washed immediately before the inﬂuenza A inoculum was added.
After 1 h of adsorption, inoculum was removed and cells were overlaid
withmediumMEM/BSA for 4 days. After 96 h of incubation at 37 °C, the
ﬂuorescence of themediumwas read (ex 530 nm, em 590 nm). Results
were expressed as 50% inhibitory concentration (IC50) (μg/mL).2.7.3. Effect of test samples during the infection
For analyzing the antiviral inhibition during the adsorption period,
inﬂuenza wasmixedwith the drug or extract and added to the cells im-
mediately. After 1 h of adsorption at 37 °C, the inoculum was removed
and cells were overlaid with medium MEM/BSA for 4 days. The anti-
inﬂuenza capacity was detected using resazurin test.2.7.4. Direct plaque assay
MDCK cell monolayer grown in MEM/BSA in 96 well culture
plates was infected with inﬂuenza virus. After 1 h adsorption at 37 °C,
viruses were removed and medium containing substances at various
concentrations/or oseltamivir were overlaid to the plates. The anti-
inﬂuenza virus capacity was assayed by quantifying of the ﬂuorescent
(ex 530 nm, em 590 nm). Results were expressed as 50% inhibitory con-
centration (IC50) (μg/mL).
2.8. Qualitative phytochemical analysis
The identiﬁcation ofmajor chemical groups of the plant extracts was
carried out by thin layer chromatography (TLC) on silica gel (60 F2SJ
glass plates, 250 μm layer thickness, Silicycle, Québec. Canada). An ali-
quot of L. densiﬂorum extract in methanol solution (1 mg/mL, 10 μL)
was directly deposited (as bands) onto the TLC plates. TLC plates were
developed in a presaturated solvent chamber with ethyl-acetate, acetic
acid/formic acid/water (100:11:11:26) as developing reagents until the
solvent front reached 1 cm from the top of plates. The developed TLC
plates were then removed from the chamber, and allowed to air-dry
for 30 min, followed by spraying with 2-aminoethyldiphenylborinate/
polyethylene glycol (NPPEG) to reveal the ﬂavonoids and phenolic
acids. For the detection of terpenoids, we use chloroform/methanol/
water (26:14:3) as mobile phase. After that, TLC plates were sprayed
with 5% H2SO4 and heated at 110 °C for 5 min. For the detection
of steroidic saponins, plates were migrated in a mixture of solvents
(chloroform/methanol) (25:1) and sprayed with 5% H2SO4 followed
by 20% vanillin. All these plates were visualized by inspection of the
plates under visible light. Each TLC plate was also monitored under UV
light at 254 and 366 nm. The retention factor of these compounds was
determined.
2.9. Statistical analysis
Means were statistically compared using the STATISTICA program.
Analysis of variance (ANOVA) and Duncan's multiple range tests were
carried out to test any signiﬁcant differences between parameters at
P b 0.05.
3. Results
3.1. Cytotoxicity effect of different extracts
Evaluation of cytotoxicity is an important part of the assessment of a
potential antiviral agent since the beneﬁcial extract should be selective
for virus-speciﬁc processes with little or no effects on the metabolisms
of host cells. All extracts were dissolved in DMSO and added to the me-
dium at a ﬁnal concentration of 1%. DMSO by itself did not exhibit any
toxic effect on Vero and MDCK cells when applied to 1%. The effect of
the extract on the growth of Vero and MDCK cells was examined by
themicroscopic analyses and determination of IC50 value of each extract
using resazurin ﬂuorometric test. Microscopically, it was observed that
all extracts do not alter the morphology or cell viability except for di-
chloromethane and methanol extracts, when their concentration
increased; morphological changes (loss of monolayer) were visible.
Dichloromethane extract decreased the viability of Vero cells. Methanol
extract has no effect on Vero cells but it reduces that of MDCK cells. This
result was conﬁrmed by the determination of the cytotoxic IC50 value of
each extract (Table 1). The IC50 values were 13.5 and 60 μg/mL for
dichloromethane and methanol extracts respectively. The remainder
extracts were not toxic for the appropriate cells.
3.2. Anti-herpes activity
Herpes virus replication is characterized by a cascade of coordinately
regulated events. The inhibitory effect of L. densiﬂorum extract was
Table 1
Cytotoxicity assay and virucidal potential of Limonium densiﬂorum extracts expressed as
IC50 values (μg/mL).
Methanol
extract
Ethanol
extract
Dichloromethane
extract
Hexane
extract
Vero cells N500 N500 13.5 ± 4 N500
MDCK cells 60 ± 15 N500 N500 N500
Herpes virus 85 ± 8 6 ± 0.5 60 ± 3 _
Inﬂuenza A 200 ± 15 189 ± 10 _ _
Data are presented as the mean values of three independent experiments including their
standard deviations.
_: absence of virucidal activity.
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tion. To identify the step at which replication might be inhibited, cells
were infected with HSV-1 after its incubation with plant extract, pre-
treatment of the virus with the extract prior to infection and addition
of the extract during or after adsorption period. In all experiments un-
treated virus infected cells were used as control. The number of plaque
formation and percent reduction was calculated relative to the amount
of virus produced in the absence of the compound. All experiments
were performed parallel with acyclovir to test the suitability of the
assay. Acyclovir achieved the highest antiviral effect when applied dur-
ing the replication period. Plaques were reduced by 90.2% at a concen-
tration of 0.75 μg/mL. When this drug was added to the cells prior to
infection, or during the infection or incubated with the herpes virus,
no antiviral effect could be observed.
3.2.1. Virucidal potential of Limonium extracts against HSV-1
The potential virucidal effect of L. densiﬂorum extracts against HSV-1
was determined by pretreatment of the virus with various concentra-
tions of extract ranging from 3.25 to 100 μg/mL, subsequent to an infec-
tion of Vero cells was done. Results displayed that ethanol, methanolFig. 1. Inﬂuence of exposure time (A) and temperature (B and C) on HSV virucidal effect using
pendent experiments including their standard deviation values.and dichloromethane extracts drastically diminished viral infectivity.
Hexane extract has no effect. Table 1 showed a dose-dependent activity
of the tested extracts. Ethanol extract exhibited levels of virucidal
activity greater than methanol and dichloromethane. The titers of
HSV-1 are reduced by 50% at a concentration of 6.5 μg/mL for ethanol
extract and at a concentration of 85 μg/mL for methanol one. Dichloro-
methane extract was inappropriate because this extract exhibited cyto-
toxicity towards Vero cells at dose from 20 μg/mL. Solvent at a ﬁnal
concentration of 1% had no effect on virus titers.
In order to analyze a possible time-dependent virucidal effect, HSV-1
was incubatedwith L. densiﬂorum extracts for different amounts of time,
ranging from 10min to 24 h. After 10, 30, 60min and 2, 18, and 24 h, an
aliquot was removed and assayed for the remaining infectivity on
conﬂuent monolayer of Vero cells. For the two extracts (ethanol and
methanol), a clearly time-independent activity (p b 0.05) was demon-
strated (Fig. 1A) and this activity was assumed to be irreversible. More-
over, to test the effect of temperature on the potential virucidal extracts,
the mixture of virus-extract was treated at two different temperatures
37 °C and 26 °C. Results showed that no signiﬁcant differences
(p b 0.05) in virion inactivation titers were found when the virus sus-
pensions were treated with the plant extracts at these two tempera-
tures for the period of 10 min, 60 min and 24 h (Fig. 1B and C). In
general, all active extracts signiﬁcantly reduced HSV-1 infectivity at dif-
ferent conditions (time and temperature).
3.2.2. Effect of test samples before virus infection
The preventive effect of L. densiﬂorum extracts on Vero cells was
determined by pre-incubation of cells with plant extract for 1 h, and
after that they were infected with HSV-1. The number of lysis plaques
formed by HSV-1 in all extracts (hexane, dichloromethane, ethanol
and methanol) pretreated Vero cells was not signiﬁcantly different
from the number formed in untreated Vero cells (Fig. 2). This suggested
that plant extracts may not protect cells from infection which clearly100 μg/mL Limonium densiﬂorum extract. Data are represented as the mean of three inde-
Fig. 2. Effect of Limoium densiﬂorum extracts on HSV-1 propagation in Vero cells when added 1 h before cell infection. No signiﬁcant difference between extracts and control (P b 0.05).
Data are represented as the mean of three independent experiments including their standard deviation values.
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the virus.
3.2.3. Effect of test samples during infection
Viruses were allowed to attach to cells in the presence of different
extracts of L. densiﬂorum for 1 h. The assay was terminated by removing
the mixture (virus-extract) with PBS (pH 7.4). Results showed that the
shoot extracts suppressed HSV-1 infectionwhen added during the virus
inoculation except for hexane extract; the activity was dose dependant.
At 100 μg/mL of extract, the inhibitory rate was higher than 70% for di-
chloromethane extract and 80% for methanol extract and it reached
100% for ethanol extract (Fig. 3A).
3.2.4. Effect of test samples after infection
Limonium extracts was assayed for anti-HSV-1 during replication
phase by the plaque reduction assay. Following virus infected cells for
60 min, inoculi were removed and 0.5% methylcellulose overlays, sup-
plemented with drug or extract, were added to the wells. After incuba-
tion for 3 days at 37 °C, lysis plaques were counted and Inhibition
Percent (IP) was calculated. Results displayed that ethanol extract has
a good effect against replication virus. At 100 μg/mL, its inhibition per-
cent (IP) against HSV-1 was 75%. Methanol extract showed a moderateFig. 3. Inhibitory effect of different concentrations of L. densiﬂorum onHSV-1 replicationwhen ad
mean of three independent experiments including their standard deviation values.activity; at the same concentrations it inhibits 42% of virus replication.
After 72 h of dichloromethane extract incubation, it was toxic for Vero
cells (Fig. 3B).
3.3. Anti-inﬂuenza activity
3.3.1. Virucidal potential of Limonium extracts
A low effect on viral growth was observed when virus was pre-
incubated with extracts before cell infection. IC50 values were 200 and
189 μg/mL respectively for methanol and ethanol extracts (Table 1). In
all steps, dichloromethane and hexane extracts did not reduce inﬂuenza
A virus production.
3.3.2. Effect of test samples before virus infection
Interestingly, pretreatment of cells with ethanol and methanol ex-
tracts has a good inhibition of virus production (IC50 = 55.5 and
100 μg/mL respectively) (Fig. 4A).
3.3.3. Effect of test samples during infection
When plant extracts were added during the adsorption period, virus
titers were reduced by 50% at a concentration of 100 μg/mL for ethanol
extract, and 155 μg/mL for methanol one (Fig. 4B).ded during viral infection (A) and afterHSV-1 penetration (B). Data are represented as the
Fig. 4. Efﬁcacy of shoot extracts on H1N1 inﬂuenza virus, when applied before viral attachment (A), or during infection (B) or after penetration of virus (C). Results are expressed as IC50
(μg/mL).
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MDCK cells were incubated with inﬂuenza virus and subsequently
with the plant extract at various concentrations. Maximum reduction
was observed with ethanol extract (IC50 = 193 μg/mL). Methanol ex-
tract was also effective against H1N1 inﬂuenza virus however, a higher
concentration was needed to achieve the same degree of reduction of
virus titers (IC50 = 250 μg/mL). Both extracts have a good anti-
inﬂuenza A activity by comparing to oseltamivir (IC50 = 30 μg/mL).
None of the hexane and dichloromethane extracts have an effect on in-
ﬂuenza replication (Fig. 4C).
3.4. TLC characterization of L. densiﬂorum
The phytochemical analysis of different extracts of L. densiﬂorum by
TLC showed that ethanol and methanol extracts present high ﬂavonoid
concentrations (detected by the yellow and orange spots) and few phe-
nolic acids (detected by blue spots), when plates were observed under
UV-light at 254 nm (Fig. 5A). This may explain the good antiviral capac-
ities of these extracts of L. densiﬂorum. Dichloromethane extract is rich
with saponins (detected by the red spots) (Fig. 5B), however hexane
contains few quantities of phenolic acids (Fig. 5B and C).
4. Discussion
Viral infections are the cause of many human and animal diseases
that have a signiﬁcant economic impact. On the basis of the fact thatFig. 5. TLC of Limonium densiﬂorum extracts. (A) Mobile phase: ethyl acetate/formic acid/ac
methanol/water (26:14:3), revelation with 5% H2SO4, (C), mobile phase: chloroform/methano80% or more of the adult human population may be sero-positive for
herpes simplex virus (HSV), this virus must be judged as a highly suc-
cessful pathogen (Cecilio et al., 2012). Furthermore, inﬂuenza continues
to emerge and cause an important health problem associated with
increase general of epidemics and occasionally pandemics, hospital
admissions and excess death (Mooney and Tompkins, 2013). Many
natural products are tested as antiviral agents because the control of
viral infection remains a challenge for researchers (Gravina et al.,
2011). Plants have a long evolutionary history with respect to develop-
ing resistance against viruses and are increasingly drawing attention as
potential sources for the development of antiviral drugs. In the present
investigation we reported for the ﬁrst time the antiviral potential of the
halophyte L. densiﬂorum. Limonum extracts have been widely used in
traditionalmedicine (Ksouri et al., 2011). Experiments to assess the tox-
icity of different plant extracts indicate that hexane and ethanol extracts
have no toxic behavior in cell cultures. However, dichloromethane and
methanol extracts show a moderate toxicity respectively towards
Vero and MDCK cells.
The antiviral activity of L. densiﬂorum extracts was dose related,
strain speciﬁc and depended on the time of virus inoculums. Interest-
ingly, extracts were quite more effective against HSV-1 than inﬂuenza.
The timing of addition experiments, aiming at investigating the possible
mode of action of Limonium extracts indicates that the pronounced
inhibitory effect can be accounted for the protection cultures and
the inhibition of early stages of viral replication or in adsorption and
penetration of the virus. Pretreatment of the Vero cells with the
L. densiﬂorum extracts had no effect on the inhibition of production ofetic acid/water (100:11:11:26), revelation with NP/PEG, (B) mobile phase: chloroform/
l (25:1), revelation with 5% H2SO4 followed with 20%vanillin.
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treatment of MCDK cells with the same extracts resulted in a good re-
duction of plaques by methanol and ethanol extracts suggesting that
L. densiﬂorum extracts have a good preventive effect on MDCK against
inﬂuenza. Probably, this extract protects the host cell infection by inter-
feringwith the action on the surface glycoproteins receptors and blocks
the attachment of the virus to cells (Nizet and Esko, 2009). When plant
extracts were added during the adsorption period, the amount of
plaques for HSV-1 was reduced by 70%, 80% and 100% respectively
for dichloromethane, ethanol and methanol extracts. A similar anti-
adsorption effect was demonstrated for the methanol and ethanol ex-
tracts inhibiting the attachment of inﬂuenza to MDCK cells (IC50 values
were respectively 155 and 102 μg/mL). This activity act can be ex-
plained by the inhibition of cellular signaling pathway (PKC/MAPK
pathway) leading to retention of viral ribonucleoprotein in nucleus,
thereby the reduction of virus replication (Ludwig, 2007). In fact, cell
fate decisions in response to extracellular agents, including pathogenic
invaders, are commonly mediated by intracellular signaling cascades
that transducer signals into stimulus speciﬁc actions. In most cases the
signal transduction within the cell is governed by kinases organized in
different kinase cascades (MAPK) (Ludwig, 2007).
After the adsorption period, the efﬁciency of L. densiﬂorum extract on
viral replication was also demonstrated in the plaque reduction assay,
since the good inhibition of HSV-1 was observed 96 h after treatment
with both ethanol andmethanol extracts, resulting in an inhibition per-
cent of viral titer of 75 and 42%, themodest inhibition of inﬂuenza yield
was expressed as IC50 (μg/mL); when treating with the same extracts
IC50 values were respectively 250 and 193 μg/mL. Therefore, extracts
of L. densiﬂorum extract showed appreciable antiviral activities on
both HSV-1 and inﬂuenza A, 96 h after viral infection compared with
the synthetic drugs ACV (100% of activity) and oseltamivir (IC50 =
30 μg/mL). When extracts were pre-incubated with virus before cell in-
fection, HSV-1 showed sensibility to ethanol extract (IC50 = 6 μg/mL).
The powerful virucidal activity against herpes virus (HSV-1) may be
caused by the disintegration of the entire HSV particles, the solubiliza-
tion of the virus envelope, and degradation or masking of some of the
essential envelope protein which are necessary for adsorption or entry
of the virus into host cells (Alvareza et al., 2009).
Accordingly, the ethanol extract tested was strongly active against
herpes viruses which made us consider that polar compounds could
be responsible for the antiviral activity. Consistent with our present
data numerous researchers have found the ethanol extract from various
plants to process antiviral activities against HSV-1 (Loizzo et al., 2008).
In another hand, Yuh-Chi et al. (2002) has isolated a new ﬂavonoid
from L. sinense shoot which suppressed HSV-1 multiplication in Vero
cells without apparent cytotoxicity. In addition, Lin et al. (2000) has iso-
lated two ﬂavonoids from the root of the same plant that inhibits the
replication of herpes virus. This suggested that the genus Limonium
could be a source of potent antiviral drugs.
Crude plant extracts contain diversity of constituents that may exert
their antiviral effect either singularly or in concert with each other. The
fact that some degree of inhibition was observed with these extracts
may suggest that the extracts contain an active component(s) in low
concentrations that may be responsible for the observed activity.
These substances may, if present at higher concentrations, be capable
to improve the inactivation of the virus aswell as preventing its replica-
tion in the host system. Previous work displayed that L. densiﬂorum ex-
tract has very high polyphenol, ﬂavonoid and tannin contents (Medini
et al., 2011); so the antiviral of the halophyte Limonium may relate to
the presence of polyphenolic compounds. Many ployphenols are
known for their anti-herpes and anti-inﬂuenza activities (Van den
Berghe et al., 1986). It is known that polyphenols bind with proteins
to form unstable complex, therefore enveloped viruses and among
them herpes and inﬂuenza A viruses may be the most vulnerable to
the action of polyphenols because this class of natural substance can
easily interact with the glycoproteins of the viral envelope (Haslam,1996). We have showed that ethanol extract rich in polyphenols has a
strong antiherpes virucidal potential. This kind of molecules exerts
their anti-inﬂuenza activity by inhibiting intracellular metabolic path-
ways rather than viral proteins. Inactivation of host-cell functions that
are essential for the virus replication offers two important advantages:
not only is it more difﬁcult for the virus to adapt to, but it can also be ex-
pected to affect viral replication (Fioravanti et al., 2012).
Usually, viral infections are accompanied with profound changes in
cell/tissue metabolism, which leads to generation of reactive oxygen
species. The latter may enhance the pathogenesis of the infection. For
example, it was found that the main cause of mortality from inﬂuenza
virus-induced pneumonia is cytotoxicity, which is determined by a
considerably increased level of O2 before viral replication in the bron-
chial epithelial cells occurs (Akaike et al., 1996). Several studies made
a correlation evaluation of the antioxidant and the antiviral activities
of plant extracts and natural substances, for example, Edziri et al.
(2012) proved that extracts from a leaf of Marrubium deserti showed
potential antioxidant capacity and it has good anti-cytomegalo and
anti-coxsakie viruses.
Halophytic vegetation, includes all classes, and grows in different
saline biotopes. In plants, unfavorable environmental conditions such
as salt constraint increase production and accumulate the reactive
oxygen species (ROS), leading to cellular damage. To overcome harmful
environment, halophytes were equipped with a powerful antioxidant
system including enzymatic and non enzymatic molecules mainly
phenolics (Ksouri et al., 2011). This hypothesis was conﬁrmed by the
measurement of the antioxidant potential of different Tunisian halo-
phytes via many tests. Results demonstrated the powerful antioxidant
capacity of L. densiﬂorum (Medini et al., 2011). In the light of this result,
we can conclude that L. densiﬂorum not only has an inhibitory effect
against herpes and inﬂuenza viruses, but also can be of great value in
preventing the inception or the progression of the disease.
The present study corroborates ethno-pharmacological data as a
valuable source in the selection of plants with antiviral activity and to
some extent validates their traditional uses.
5. Conclusion
This study has shown that L. densiﬂorum extracts can inhibit both
(H1N1) inﬂuenza and HSV-1 viruses by inhibiting the early stage of
HSV multiplication, along with a good protection of cells against inﬂu-
enza virus. These results lead to further investigation about the charac-
terization of active compounds and their speciﬁc mechanism against
these viruses. In addition, L. densiﬂorum was rich in phenolic com-
pounds so it can be interesting in preventing the inception or the pro-
gression of the disease. Given the urgent need for new and abundantly
available anti-inﬂuenza and anti-herpes drugs, L. densiﬂorum ethanol
extract appear to be a promising option as a replacement or supplemen-
tal strategy to currently available antiviral therapies.
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